Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth Potential
Pathobiology · 2021 · 88 (5) · 374-382
DOI: 10.1159/000514593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, online erschienen am 01.04.2021. Verfasst von Shusaku Kurogi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan. Hauptthemen laut MEDLINE: Disease Progression, Down-Regulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Progression of pancreatic intraepithelial neoplasia (PanIN) to invasive carcinoma is a critical factor impacting the prognosis of patients with pancreatic tumors. However, the molecular mechanisms involved are not fully understood. We have reported that the process frequently involves loss of chromosome 8p, causing downregulation of DUSP4, thus conferring invasive ability on cancer cells. Here, we focus on ZNF395, whose expression was also found to be decreased by 8p loss and was predicted to be a growth suppressor gene.
Methods
Pancreatic cancer cell lines inducibly expressing ZNF395 were established to assess the functional significance of ZNF395 in pancreatic carcinogenesis. Immunohistochemistry was also performed to analyze the expression levels of ZNF395 in pancreatic cancer tissues.
Results
Induction of ZNF395 in pancreatic cancer cells resulted in marked activation of JNK and suppression of their proliferation through a delay in cell cycle progression. Immunohistochemistry revealed that ZNF395 was expressed ubiquitously in both normal pancreatic ducts and PanINs but was significantly reduced in invasive cancers, especially those showing poor differentiation.
Conclusion
ZNF395 acts as a novel tumor suppressor gene. Its downregulation caused by 8p loss in intraepithelial cells accelerates their proliferation through dysregulation of the cell cycle, leading to progression to invasive cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathology, Faculty of Medicine, Oita University, Yufu, Japan.
- Department of Infectious Disease Control, Faculty of Medicine, Oita University, Yufu, Japan.
- Shinbeppu Hospital, Beppu, Japan.
- Department of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University, Yufu, Japan.
- Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan.
- Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Zitieren
APA
Kurogi, S., Hijiya, N., Hidano, S., Sato, S., Uchida, T., Tsukamoto, Y., Nakada, C., Yada, K., Hirashita, T., Inomata, M., Murakami, K., Takahashi, N., Kobayashi, T., & Moriyama, M. (2021). Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth Potential. Pathobiology, 88(5), 374-382. https://doi.org/10.1159/000514593
Vancouver
Kurogi S, Hijiya N, Hidano S, Sato S, Uchida T, Tsukamoto Y, et al. Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth Potential. Pathobiology. 2021;88(5):374-382. doi:10.1159/000514593
BibTeX
@article{Kurogi2021,
author = {Kurogi, Shusaku and Hijiya, Naoki and Hidano, Shinya and Sato, Seiya and Uchida, Tomohisa and Tsukamoto, Yoshiyuki and Nakada, Chisato and Yada, Kazuhiro and Hirashita, Teijiro and Inomata, Masafumi and Murakami, Kazunari and Takahashi, Naohiko and Kobayashi, Takashi and Moriyama, Masatsugu},
title = {Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth Potential},
journal = {Pathobiology},
year = {2021},
volume = {88},
number = {5},
pages = {374--382},
doi = {10.1159/000514593}
}
EUVIMED